LON:ERGO

Ergomed - ERGO Share Forecast, Price & News

GBX 992

-36.00 (-3.50%)

(As of 03/28/2023 04:52 PM ET)

Add

Compare

Today's Range: 988
▼
1,038.50
50-Day Range: 997
▼
1,314
52-Week Range: 910
▼
1,478

Volume: 253,290 shs
Average Volume: 124,572 shs
Market Capitalization: £499.97 million

P/E Ratio: 3,815.38
Dividend Yield: N/A
Price Target: GBX 1,525

Ergomed MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 53.7% Upside
GBX 1,525 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.28
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.79 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Ergomed has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 1,525, Ergomed has a forecasted upside of 53.7% from its current price of GBX 992.
Amount of Analyst Coverage
Ergomed has only been the subject of 3 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for ERGO.

0.0

Dividend Strength

Dividend Yield
Ergomed does not currently pay a dividend.
Dividend Growth
Ergomed does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ERGO.

1.8

News and Social Media Coverage

News Sentiment
Ergomed has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Ergomed this week, compared to 0 articles on an average week.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Ergomed insiders have not sold or bought any company stock.
Percentage Held by Insiders
19.47% of the stock of Ergomed is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
67.09% of the stock of Ergomed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Ergomed is 3,815.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 116.61.
Price to Earnings Ratio vs. Sector
The P/E ratio of Ergomed is 3,815.38, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 95.61.
Price to Book Value per Share Ratio
Ergomed has a P/B Ratio of 6.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Ergomed (LON:ERGO) Stock

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.

Receive ERGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ergomed and its competitors with MarketBeat's FREE daily newsletter.

ERGO Stock News Headlines

March 24, 2023 | americanbankingnews.com

Shore Capital Reiterates Hold Rating for Ergomed (LON:ERGO)

March 23, 2023 | americanbankingnews.com

Ergomed (LON:ERGO) Rating Reiterated by Berenberg Bank

March 28, 2023 | Stansberry Research (Ad)

The gold catalyst we’ve waited for

If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.

March 22, 2023 | finance.yahoo.com

Ergomed Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

March 20, 2023 | finance.yahoo.com

Estimating The Fair Value Of Ergomed plc (LON:ERGO)

February 26, 2023 | msn.com

Just released: the 3 best small-cap stocks to buy now [PREMIUM PICKS]

February 21, 2023 | marketwatch.com

Pharmacovigilance Outsourcing Market 2023 Size, Share, Growth, Analysis, Trends and Forecast to 2028

February 20, 2023 | finance.yahoo.com

If EPS Growth Is Important To You, Ergomed (LON:ERGO) Presents An Opportunity

March 28, 2023 | Weiss Ratings (Ad)

Bank Accounts: Frozen!

In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!

January 25, 2023 | morningstar.com

EasyJet Shares Jump After Upbeat 1Q, Strong Outlook

January 25, 2023 | marketwatch.com

Ergomed Sees 2022 Adjusted Earnings Meeting Market Views; Names New CFO

January 23, 2023 | finance.yahoo.com

When Should You Buy Ergomed plc (LON:ERGO)?

December 28, 2022 | uk.finance.yahoo.com

Ergomed plc (ERGO.L)

November 28, 2022 | finance.yahoo.com

Are Robust Financials Driving The Recent Rally In Ergomed plc's (LON:ERGO) Stock?

November 21, 2022 | markets.businessinsider.com

Ergomed (ERGO): Two key management changes

November 17, 2022 | marketwatch.com

Ergomed Names Jonathan Curtain as Deputy CFO

October 30, 2022 | finance.yahoo.com

The 9.0% return this week takes Ergomed's (LON:ERGO) shareholders five-year gains to 484%

October 10, 2022 | finance.yahoo.com

Is There An Opportunity With Ergomed plc's (LON:ERGO) 29% Undervaluation?

October 4, 2022 | markets.businessinsider.com

Ergomed (ERGO): Poised for a strong FY22

September 13, 2022 | finance.yahoo.com

Does Ergomed (LON:ERGO) Deserve A Spot On Your Watchlist?

September 8, 2022 | markets.businessinsider.com

Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations

August 14, 2022 | finance.yahoo.com

Is There Now An Opportunity In Ergomed plc (LON:ERGO)?

August 1, 2022 | markets.businessinsider.com

Ergomed (ERGO): Sustained growth momentum in H122

July 28, 2022 | lse.co.uk

Ergomed posts strong growth after Adamas acquisition

July 27, 2022 | proactiveinvestors.com

Ergomed revenues rise 25% as pharma services demand stays healthy

July 27, 2022 | marketwatch.com

Ergomed Expects 2022 Performance in Line With Market Views

June 18, 2022 | finance.yahoo.com

Ergomed plc (LON:ERGO) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ERGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ergomed and its competitors with MarketBeat's FREE daily newsletter.

ERGO Company Calendar

Last Earnings: 9/18/2017
Today: 3/28/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:ERGO
CUSIP: N/A
CIK: N/A
Web: www.ergomedplc.com
Phone: +44-1483-503205
Fax: N/A
Employees: 1,371
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: GBX 1,525
High Stock Price Forecast: GBX 1,600
Low Stock Price Forecast: GBX 1,450
Forecasted Upside/Downside: +53.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX 0.26
Trailing P/E Ratio: 3,811.54
Forward P/E Ratio: 24.08
P/E Growth: N/A
Net Income: £13.36 million
Net Margins: 10.08%
Pretax Margin: N/A
Return on Equity: 19.93%
Return on Assets: 11.87%

Debt

Debt-to-Equity Ratio: 3.45
Current Ratio: 1.26
Quick Ratio: 1.22

Sales & Book Value

Annual Sales: £132.46 million
Price / Sales: 3.77
Cash Flow: GBX 18.13 per share
Price / Cash Flow: 54.67
Book Value: GBX 150 per share
Price / Book: 6.61

Miscellaneous

Outstanding Shares: 50,400,000
Free Float: N/A
Market Cap: £499.46 million
Optionable: Not Optionable
Beta: 0.88

Key Executives

Dr. Miroslav Reljanovic (Age 64)
Founder & Exec. Chairman
Comp: $641.1k

Mr. Richard T. Barfield (Age 65)
CFO & Exec. Director
Comp: $438.78k

Mr. Michael William Spiteri (Age 62)
Chief Transformation & Technology Officer
Comp: $60k

Mr. Shaun Hopgood
Chief Information Officer

Dr. Michael Forstner
Head of Risk Management & Pharmacoepidemiology

Ms. Sally Amanuel
Pres of PrimeVigilance

Dr. Gordana Tonkovic
Pres of Clinical Research

Ms. Ronel Steyn
Sr. VP of Global Devel.

Keith Byrne
Sr. Vice-Pres of Capital Markets & Strategy

Jonathan Curtain
Deputy CFO

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

ERGO Stock - Frequently Asked Questions

Should I buy or sell Ergomed stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ergomed in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ERGO shares.
View ERGO analyst ratings or view top-rated stocks.
What is Ergomed's stock price forecast for 2023?: 3 equities research analysts have issued 12-month price objectives for Ergomed's shares. Their ERGO share price forecasts range from GBX 1,450 to GBX 1,600. On average, they anticipate the company's share price to reach GBX 1,525 in the next twelve months. This suggests a possible upside of 53.9% from the stock's current price.
View analysts price targets for ERGO or view top-rated stocks among Wall Street analysts.
How have ERGO shares performed in 2023?: Ergomed's stock was trading at GBX 1,272 at the beginning of the year. Since then, ERGO shares have decreased by 22.1% and is now trading at GBX 991.
View the best growth stocks for 2023 here.
How were Ergomed's earnings last quarter?: Ergomed plc (LON:ERGO) announced its quarterly earnings results on Monday, September, 18th. The company reported $1.20 EPS for the quarter. The firm earned $22.91 million during the quarter. Ergomed had a trailing twelve-month return on equity of 19.93% and a net margin of 10.08%.
What other stocks do shareholders of Ergomed own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Ergomed investors own include Dicerna Pharmaceuticals (DRNA), AbbVie (ABBV), Axsome Therapeutics (AXSM), FuelCell Energy (FCEL), NIO (NIO), Science Applications International (SAIC), Northern Dynasty Minerals (NAK), Tilray (TLRY), Agilent Technologies (A) and American Express (AXP).

What is Ergomed's stock symbol?: Ergomed trades on the London Stock Exchange (LON) under the ticker symbol "ERGO."
How do I buy shares of Ergomed?: Shares of ERGO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Ergomed's stock price today?: One share of ERGO stock can currently be purchased for approximately GBX 991.
How much money does Ergomed make?: Ergomed (LON:ERGO) has a market capitalization of £499.46 million and generates £132.46 million in revenue each year. The company earns £13.36 million in net income (profit) each year or GBX 0.26 on an earnings per share basis.
How many employees does Ergomed have?: The company employs 1,371 workers across the globe.
How can I contact Ergomed?: Ergomed's mailing address is 26-24 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The official website for the company is www.ergomedplc.com. The company can be reached via phone at +44-1483-503205.

This page (LON:ERGO) was last updated on 3/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ergomed - ERGO Share Forecast, Price & News

Ergomed MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About Ergomed (LON:ERGO) Stock

ERGO Stock News Headlines

ERGO Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

ERGO Stock - Frequently Asked Questions

Overall MarketRank^™